OHR Pharmaceutical Inc.

About OHR

OHR Pharmaceutical Pipeline

OHR is focused on the development of novel therapeutics for the treatment of serious and unmet medical needs.

Learn More

Latest News

Ohr Pharmaceutical Announces Squalamine Eye Drop (OHR-102) Clinical Data Presentations at the Retina Society 47th Annual Scientific Meeting

Read More »

Ohr Pharmaceutical Announces Additional Squalamine Eye Drop (OHR-102) Phase II Clinical Data in Wet-AMD; The IMPACT Study

Read More »
View All News